SK285149B6 - Použitie substituovaných cyklohexánových zlúčenínna liečenie COPD - Google Patents
Použitie substituovaných cyklohexánových zlúčenínna liečenie COPD Download PDFInfo
- Publication number
- SK285149B6 SK285149B6 SK1023-2000A SK10232000A SK285149B6 SK 285149 B6 SK285149 B6 SK 285149B6 SK 10232000 A SK10232000 A SK 10232000A SK 285149 B6 SK285149 B6 SK 285149B6
- Authority
- SK
- Slovakia
- Prior art keywords
- cyano
- methoxyphenyl
- cyclohexane
- cis
- cyclopropylmethoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Indole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7071898P | 1998-01-07 | 1998-01-07 | |
| US10690898P | 1998-10-28 | 1998-10-28 | |
| PCT/US1999/000214 WO1999034798A1 (fr) | 1998-01-07 | 1999-01-06 | Procede pour le traitement de la bronchopneumopathie chronique obstructive |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK10232000A3 SK10232000A3 (sk) | 2001-01-18 |
| SK285149B6 true SK285149B6 (sk) | 2006-07-07 |
Family
ID=26751429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1023-2000A SK285149B6 (sk) | 1998-01-07 | 1999-01-06 | Použitie substituovaných cyklohexánových zlúčenínna liečenie COPD |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6369108B1 (fr) |
| EP (1) | EP1051172B1 (fr) |
| JP (1) | JP2003522095A (fr) |
| KR (1) | KR100555824B1 (fr) |
| CN (1) | CN1291891A (fr) |
| AP (1) | AP2000001859A0 (fr) |
| AR (1) | AR014411A1 (fr) |
| AT (1) | ATE285234T1 (fr) |
| AU (1) | AU752497B2 (fr) |
| BG (1) | BG104654A (fr) |
| BR (1) | BR9906803A (fr) |
| CA (1) | CA2317720A1 (fr) |
| DE (1) | DE69922786T2 (fr) |
| DZ (1) | DZ2703A1 (fr) |
| EA (1) | EA006382B1 (fr) |
| EG (1) | EG23945A (fr) |
| ES (1) | ES2234234T3 (fr) |
| HK (1) | HK1033551A1 (fr) |
| HU (1) | HUP0100888A3 (fr) |
| ID (1) | ID26164A (fr) |
| IL (1) | IL137104A0 (fr) |
| MA (1) | MA26592A1 (fr) |
| MY (1) | MY133014A (fr) |
| NO (1) | NO20003481L (fr) |
| NZ (1) | NZ505521A (fr) |
| OA (1) | OA11443A (fr) |
| PE (1) | PE20000231A1 (fr) |
| PL (1) | PL341667A1 (fr) |
| PT (1) | PT1051172E (fr) |
| SI (1) | SI1051172T1 (fr) |
| SK (1) | SK285149B6 (fr) |
| TR (1) | TR200001819T2 (fr) |
| UY (1) | UY25338A1 (fr) |
| WO (1) | WO1999034798A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ3019A1 (fr) | 1999-03-01 | 2005-05-20 | Smithkline Beecham Corp | Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd. |
| AR024076A1 (es) * | 1999-05-25 | 2002-09-04 | Smithkline Beecham Corp | Sales de cis-[4-ciano-4-(3-ciclopentiloxi-4-metoxifenil) ciclohexan-1-carboxilato] |
| IL148032A0 (en) * | 1999-08-10 | 2002-09-12 | Smithkline Beecham Corp | 1,4-substituted 4,4-diaryl cyclohexanes |
| WO2001043692A2 (fr) * | 1999-12-15 | 2001-06-21 | Smithkline Beecham Corporation | SELS D'ACIDE CARBOXYLIQUE Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1 |
| EP1265861A2 (fr) | 2000-03-16 | 2002-12-18 | Inflazyme Pharmaceuticals, Ltd. | Inhibiteurs benzyles de pde4 |
| DE10245153A1 (de) * | 2002-09-27 | 2004-04-15 | Infineon Technologies Ag | Integrierter Feldeffekttransistor mit zwei Steuerbereichen, Verwendung dieses Feldeffekttranistors und Herstellungsverfahren |
| WO2006129164A1 (fr) | 2005-05-31 | 2006-12-07 | Pfizer Japan Inc. | Composes aryloxy-n-bicyclomethyl acetamide substitues en tant qu'agonistes vr1 |
| MY148903A (en) | 2007-06-05 | 2013-06-14 | Sanofi Aventis | Di(hetero)arylclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0633776B1 (fr) * | 1992-04-02 | 2001-05-09 | Smithkline Beecham Corporation | Composes destines a traiter les maladies allergiques et inflammatoires |
| EP0633771A4 (en) * | 1992-04-02 | 1995-02-22 | Smithkline Beecham Corporation | Compounds. |
| GB9525262D0 (en) * | 1995-12-11 | 1996-02-07 | Bayer Ag | Heterocyclylcarbonyl substituted benzofuranyl-ureas |
-
1998
- 1998-12-31 UY UY25338A patent/UY25338A1/es not_active Application Discontinuation
-
1999
- 1999-01-04 MA MA25416A patent/MA26592A1/fr unknown
- 1999-01-05 MY MYPI99000027A patent/MY133014A/en unknown
- 1999-01-06 AP APAP/P/2000/001859A patent/AP2000001859A0/en unknown
- 1999-01-06 PE PE1999000011A patent/PE20000231A1/es not_active Application Discontinuation
- 1999-01-06 KR KR1020007007487A patent/KR100555824B1/ko not_active IP Right Cessation
- 1999-01-06 TR TR2000/01819T patent/TR200001819T2/xx unknown
- 1999-01-06 SK SK1023-2000A patent/SK285149B6/sk not_active IP Right Cessation
- 1999-01-06 EA EA200000740A patent/EA006382B1/ru not_active IP Right Cessation
- 1999-01-06 CA CA002317720A patent/CA2317720A1/fr not_active Abandoned
- 1999-01-06 PL PL99341667A patent/PL341667A1/xx not_active IP Right Cessation
- 1999-01-06 IL IL13710499A patent/IL137104A0/xx not_active IP Right Cessation
- 1999-01-06 BR BR9906803-6A patent/BR9906803A/pt not_active Application Discontinuation
- 1999-01-06 PT PT99901337T patent/PT1051172E/pt unknown
- 1999-01-06 CN CN99803407A patent/CN1291891A/zh active Pending
- 1999-01-06 US US09/582,739 patent/US6369108B1/en not_active Expired - Fee Related
- 1999-01-06 WO PCT/US1999/000214 patent/WO1999034798A1/fr active IP Right Grant
- 1999-01-06 JP JP2000527247A patent/JP2003522095A/ja active Pending
- 1999-01-06 ID IDW20001314A patent/ID26164A/id unknown
- 1999-01-06 NZ NZ505521A patent/NZ505521A/xx unknown
- 1999-01-06 HU HU0100888A patent/HUP0100888A3/hu unknown
- 1999-01-06 EP EP99901337A patent/EP1051172B1/fr not_active Expired - Lifetime
- 1999-01-06 AT AT99901337T patent/ATE285234T1/de not_active IP Right Cessation
- 1999-01-06 EG EG1499A patent/EG23945A/xx active
- 1999-01-06 AU AU21060/99A patent/AU752497B2/en not_active Ceased
- 1999-01-06 DZ DZ990004A patent/DZ2703A1/fr active
- 1999-01-06 SI SI9930757T patent/SI1051172T1/xx unknown
- 1999-01-06 DE DE69922786T patent/DE69922786T2/de not_active Expired - Fee Related
- 1999-01-06 ES ES99901337T patent/ES2234234T3/es not_active Expired - Lifetime
- 1999-01-08 AR ARP990100057A patent/AR014411A1/es unknown
-
2000
- 2000-07-06 NO NO20003481A patent/NO20003481L/no not_active Application Discontinuation
- 2000-07-07 OA OA1200000199A patent/OA11443A/en unknown
- 2000-08-01 BG BG104654A patent/BG104654A/xx unknown
-
2001
- 2001-04-18 HK HK01102756A patent/HK1033551A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019204493B2 (en) | Pharmaceutical compositions comprising PPAR agonists and Nrf2 activators | |
| RU2214999C2 (ru) | Производное 3-арил-2-гидроксипропионовой кислоты, способ его получения(варианты), фармацевтический препарат, способ лечения и промежуточный продукт | |
| DE69813896T2 (de) | Alpha-aminoamidderivate die als analgetische mittel nützlich sind | |
| CN102333764B (zh) | 取代的吡咯衍生物、含这些衍生物的药用组合物以及用其治疗帕金森氏病的方法 | |
| BG62235B1 (bg) | Съединения за лечение на алергични заболявания и възпалителнипроцеси | |
| KR20110027657A (ko) | 카르복실산 화합물 | |
| HUT64514A (en) | Process for producing arylic comdounds with anti-atherosclerotic effect | |
| RU2010141823A (ru) | Соединения и способ снижения мочевой кислоты | |
| US6563009B1 (en) | Vasodilator cannabinoid analogs | |
| CA3037146A1 (fr) | Methode de reduction des effets secondaires associes a la thyroide | |
| MXPA05000050A (es) | Composiciones farmaceuticas y metodos para tratar, prevenir y manejar el colesterol, dislipidemia y enfermedades relacionadas. | |
| SK285149B6 (sk) | Použitie substituovaných cyklohexánových zlúčenínna liečenie COPD | |
| SK7662002A3 (en) | Comminuted form of (s)-2-ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid | |
| MX2007012070A (es) | Tratamiento de la epilepsia con ligandos del receptor h3 de histamina, tipo alquilaminas no imidazol. | |
| AU2004275637A1 (en) | Method of inhibiting remnant lipoprotein production | |
| US10583141B2 (en) | N-substituted hydroxamic acids with carbon-based leaving groups as efficient HNO donors and uses thereof | |
| JP4602969B2 (ja) | 過活動膀胱を治療するためのフェノキシ酢酸誘導体の使用 | |
| JP2007513173A (ja) | ロシグリタゾンを用いる乾癬の治療 | |
| EP1642594A1 (fr) | Remede contre des maladies des voies urinaires | |
| MXPA00006704A (en) | Method for treating copd | |
| CZ20002530A3 (cs) | Farmaceutický prostředek, způsob profylaxe, použití pro výrobu léčiva, způsob jeho výroby a léčivo | |
| JP4231785B2 (ja) | 酪酸誘導体 | |
| CA2317548A1 (fr) | Methode de traitement de la sclerose en plaques | |
| US3988454A (en) | Phenylalkylaralkylamines for pharmaceutical use | |
| TWI235058B (en) | Method for treating COPD |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100106 |